You are here: Home > Our Business > Pipeline

Pipeline

MCV4

1533545504963911.jpg

MCV4 is a vaccine used for the prevention of N. meningitides

 (Lta). Our MCV4 candidate is a potential first-in-class vaccine

 in China. Meningococcal polysaccharide vaccines are primarily

 used in China. Developed countries have replaced polysaccharide

 products with MCV4 products. As of the Latest Practicable Date,

 there was no approved MCV4 in China.